Suppr超能文献

序贯性痉挛激发试验可能会克服标准痉挛激发试验的一个局限性。

Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.

作者信息

Sueda Shozo, Miyoshi Toru, Sasaki Yasuhiro, Sakaue Tomoki, Habara Hirokazu, Kohno Hiroaki

机构信息

Department of Cardiology, Ehime Prefectural Niihama Hospital, Niihama, Japan.

出版信息

Coron Artery Dis. 2015 Sep;26(6):490-4. doi: 10.1097/MCA.0000000000000267.

Abstract

OBJECTIVE

We examined the clinical usefulness of sequential spasm provocation tests as follows: first, acetylcholine (ACh) test, second, ergonovine (ER) test, and finally, the ACh test following the ER test.

PATIENTS AND METHODS

We performed the ACh and ER tests in 461 patients (294 men, 64.4±11.3 years of age) during a 23-year period. In addition, we administered an intracoronary injection of ACh after the ER tests in 240 patients. First, ACh [right coronary artery (RCA): 20/50/(80) μg, left coronary artery (LCA): 20/50/100/(200) μg] was administered incrementally over 20 s. Second, ER (RCA: 40 μg, LCA: 64 μg) was administered over 2-4 min. If a provoked spasm did not occur, we administered an intracoronary injection of ACh (50/80 μg into the RCA and 100/200 μg into the LCA) just after the ER tests. A positive spasm was defined as more than 99% transient luminal narrowing.

RESULTS

A positive spasm was observed in 221 (47.9%) patients including 181 ACh-positive (39.3%) and 119 ER-positive (25.8%) patients by the ACh or ER tests. In the 240 patients with a negative spasm in the ACh and ER tests, 48 (10.4%) patients developed provoked spasms on adding ACh after the ER test. The distributions of various cardiac disorders and provoked spasm vessels were similar among the three positive groups. Focal spasm was frequently observed in the ER-positive group, whereas diffuse spasm was frequently obtained in the ACh-positive group and by adding ACh after ER in the positive group. No major complications were recognized during the sequential spasm provocation tests.

CONCLUSION

Sequential spasm provocation tests might overcome a limitation of standard spasm provocation tests.

摘要

目的

我们对以下序贯性痉挛激发试验的临床实用性进行了研究:首先是乙酰胆碱(ACh)试验,其次是麦角新碱(ER)试验,最后是ER试验后的ACh试验。

患者与方法

在23年期间,我们对461例患者(294例男性,年龄64.4±11.3岁)进行了ACh和ER试验。此外,我们对240例患者在ER试验后进行了冠状动脉内注射ACh。首先,在20秒内递增注射ACh[右冠状动脉(RCA):20/50/(80)μg,左冠状动脉(LCA):20/50/100/(200)μg]。其次,在2 - 4分钟内注射ER(RCA:40μg,LCA:64μg)。如果未诱发痉挛,我们在ER试验后立即进行冠状动脉内注射ACh(RCA注射50/80μg,LCA注射100/200μg)。阳性痉挛定义为管腔瞬间狭窄超过99%。

结果

通过ACh或ER试验,在221例(47.9%)患者中观察到阳性痉挛,其中包括181例ACh阳性(39.3%)和119例ER阳性(25.8%)患者。在ACh和ER试验中痉挛阴性的240例患者中,48例(10.4%)患者在ER试验后加用ACh时出现诱发痉挛。三个阳性组中各种心脏疾病和诱发痉挛血管的分布相似。ER阳性组中局灶性痉挛较为常见,而ACh阳性组以及ER试验后加用ACh的阳性组中弥漫性痉挛较为常见。序贯性痉挛激发试验期间未发现重大并发症。

结论

序贯性痉挛激发试验可能克服标准痉挛激发试验的局限性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验